scispace - formally typeset
F

Frank J P M Huygen

Researcher at Erasmus University Rotterdam

Publications -  229
Citations -  8972

Frank J P M Huygen is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Complex regional pain syndrome & Chronic pain. The author has an hindex of 48, co-authored 196 publications receiving 7579 citations. Previous affiliations of Frank J P M Huygen include Erasmus University Medical Center.

Papers
More filters
Journal ArticleDOI

The incidence of complex regional pain syndrome: a population-based study.

TL;DR: The observed incidence rate of CRPS is more as four times higher than the incidence rate observed in the only other population‐based study, performed in Olmsted County, USA.
Journal ArticleDOI

Incidence of facial pain in the general population.

TL;DR: It is concluded that facial pain is relatively rare, although more common than estimated previously based on hospital data, and was more common in men than women.
Journal ArticleDOI

Evidence for local inflammation in complex regional pain syndrome type 1.

TL;DR: This is the first time that involvement of mediators of inflammation in CRPS 1 has been so clearly and directly demonstrated and opens new approaches for the succesful use and development of immunosuppressives inCRPS 1.
Journal ArticleDOI

Incidence rates and treatment of neuropathic pain conditions in the general population.

TL;DR: The treatment mostly consisted of regular analgesics suggesting that pharmacological treatment of neuropathic pain is suboptimal, with an annual incidence of almost 1% of the general population and affecting women and middle‐aged persons more often.
Journal ArticleDOI

Anti-inflammatory actions of acupuncture

TL;DR: Mechanisms underlying the ascribed immunosuppressive actions of acupuncture are reviewed and the complex interactions with substance P, the analgesic contribution of beta-endorphin and the balance between cell-specific pro-inflammatory and anti-inflammatory cytokines tumour necrosis factor-alpha and interleukin-10 are discussed.